NDD-20491-50584
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 275 / NC
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Registered in v-safe
- 2021-01-26
-
2021-02-04
Survey response — day 28, dose 1MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Head cold, negative for Covid but had to delay 2nd doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 28, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-13
- 2021-02-15
- 2021-02-16
- 2021-02-26
- 2021-08-10
- 2022-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — day 28, dose 1
Symptoms: Head cold, negative for Covid but had to delay 2nd dose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release